カテゴリー： QYResearch, 世界

世界の組換体抗体市場 2019年

【英語タイトル】Global Recombinant Antibody Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14170）・商品コード：DATA909X14170
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、組換体抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体に、用途別には、病院、科学研究、その他にセグメント区分し、組換体抗体の世界市場を分析しました。


・エグゼクティブ・サマリー
・組換体抗体の世界市場概要
・組換体抗体の製造コスト構成分析
・組換体抗体の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・組換体抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・組換体抗体のセグメント分析（種類別）
（キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体）
・組換体抗体のセグメント分析（用途別）
（病院、科学研究、その他）
・組換体抗体の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abnova、Medix Biochemica、GE Healthcare、SinoBiological、Bioventix、）
・組換体抗体の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Recombinant Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Antibody market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Antibody in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Antibody manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody

Segment by Application
Hospital
Scientific Research
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Recombinant Antibody
1.1 Definition of Recombinant Antibody
1.2 Recombinant Antibody Segment by Type
1.2.1 Global Recombinant Antibody Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Chimeric Antibody
1.2.3 Humanized Antibody
1.2.4 Full Human Antibody
1.2.5 Single Chain Antibody
1.2.6 Bispecific Antibody
1.3 Recombinant Antibody Segment by Applications
1.3.1 Global Recombinant Antibody Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Antibody Overall Market
1.4.1 Global Recombinant Antibody Revenue (2014-2025)
1.4.2 Global Recombinant Antibody Production (2014-2025)
1.4.3 North America Recombinant Antibody Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Antibody Status and Prospect (2014-2025)
1.4.5 China Recombinant Antibody Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Antibody Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Antibody Status and Prospect (2014-2025)
1.4.8 India Recombinant Antibody Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Antibody
2.3 Manufacturing Process Analysis of Recombinant Antibody
2.4 Industry Chain Structure of Recombinant Antibody

3 Development and Manufacturing Plants Analysis of Recombinant Antibody
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Antibody Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Antibody
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Recombinant Antibody Production and Capacity Analysis
4.2 Recombinant Antibody Revenue Analysis
4.3 Recombinant Antibody Price Analysis
4.4 Market Concentration Degree

5 Recombinant Antibody Regional Market Analysis
5.1 Recombinant Antibody Production by Regions
5.1.1 Global Recombinant Antibody Production by Regions
5.1.2 Global Recombinant Antibody Revenue by Regions
5.2 Recombinant Antibody Consumption by Regions
5.3 North America Recombinant Antibody Market Analysis
5.3.1 North America Recombinant Antibody Production
5.3.2 North America Recombinant Antibody Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Antibody Import and Export
5.4 Europe Recombinant Antibody Market Analysis
5.4.1 Europe Recombinant Antibody Production
5.4.2 Europe Recombinant Antibody Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Antibody Import and Export
5.5 China Recombinant Antibody Market Analysis
5.5.1 China Recombinant Antibody Production
5.5.2 China Recombinant Antibody Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Antibody Import and Export
5.6 Japan Recombinant Antibody Market Analysis
5.6.1 Japan Recombinant Antibody Production
5.6.2 Japan Recombinant Antibody Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Antibody Import and Export
5.7 Southeast Asia Recombinant Antibody Market Analysis
5.7.1 Southeast Asia Recombinant Antibody Production
5.7.2 Southeast Asia Recombinant Antibody Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Antibody Import and Export
5.8 India Recombinant Antibody Market Analysis
5.8.1 India Recombinant Antibody Production
5.8.2 India Recombinant Antibody Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Antibody Import and Export

6 Recombinant Antibody Segment Market Analysis (by Type)
6.1 Global Recombinant Antibody Production by Type
6.2 Global Recombinant Antibody Revenue by Type
6.3 Recombinant Antibody Price by Type

7 Recombinant Antibody Segment Market Analysis (by Application)
7.1 Global Recombinant Antibody Consumption by Application
7.2 Global Recombinant Antibody Consumption Market Share by Application (2014-2019)

8 Recombinant Antibody Major Manufacturers Analysis
8.1 Abnova
8.1.1 Abnova Recombinant Antibody Production Sites and Area Served
8.1.2 Abnova Product Introduction, Application and Specification
8.1.3 Abnova Recombinant Antibody Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Medix Biochemica
8.2.1 Medix Biochemica Recombinant Antibody Production Sites and Area Served
8.2.2 Medix Biochemica Product Introduction, Application and Specification
8.2.3 Medix Biochemica Recombinant Antibody Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GE Healthcare
8.3.1 GE Healthcare Recombinant Antibody Production Sites and Area Served
8.3.2 GE Healthcare Product Introduction, Application and Specification
8.3.3 GE Healthcare Recombinant Antibody Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 SinoBiological
8.4.1 SinoBiological Recombinant Antibody Production Sites and Area Served
8.4.2 SinoBiological Product Introduction, Application and Specification
8.4.3 SinoBiological Recombinant Antibody Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Bioventix
8.5.1 Bioventix Recombinant Antibody Production Sites and Area Served
8.5.2 Bioventix Product Introduction, Application and Specification
8.5.3 Bioventix Recombinant Antibody Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Recombinant Antibody Market
9.1 Global Recombinant Antibody Market Trend Analysis
9.1.1 Global Recombinant Antibody Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Antibody Regional Market Trend
9.2.1 North America Recombinant Antibody Forecast 2019-2025
9.2.2 Europe Recombinant Antibody Forecast 2019-2025
9.2.3 China Recombinant Antibody Forecast 2019-2025
9.2.4 Japan Recombinant Antibody Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Antibody Forecast 2019-2025
9.2.6 India Recombinant Antibody Forecast 2019-2025
9.3 Recombinant Antibody Market Trend (Product Type)
9.4 Recombinant Antibody Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Antibody Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Recombinant Antibody
Table Global Recombinant Antibody Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Antibody Production Market Share by Types in 2018
Figure Chimeric Antibody Product Picture
Figure Humanized Antibody Product Picture
Figure Full Human Antibody Product Picture
Figure Single Chain Antibody Product Picture
Figure Bispecific Antibody Product Picture
Table Global Recombinant Antibody Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Recombinant Antibody Consumption Market Share by Applications in 2018
Figure Hospital
Figure Scientific Research
Figure Others
Figure Global Recombinant Antibody Revenue (Million USD) (2014-2025)
Figure Global Recombinant Antibody Production (K Units) (2014-2025)
Figure North America Recombinant Antibody Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Antibody Market Size (Million USD) (2014-2025)
Figure China Recombinant Antibody Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Antibody Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Antibody Market Size (Million USD) (2014-2025)
Figure India Recombinant Antibody Market Size (Million USD) (2014-2025)
Table Recombinant Antibody Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Antibody in 2018
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Industry Chain Structure of Recombinant Antibody
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Antibody Manufacturing Plants Distribution
Table Recombinant Antibody Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Antibody Capacity (K Units) of Major Manufacturers (2014-2019)
Table Recombinant Antibody Production (K Units) of Major Manufacturers (2014-2019)
Table Recombinant Antibody Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Antibody Production Share by Manufacturers in 2018
Table Recombinant Antibody Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Antibody Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Antibody Revenue Share by Manufacturers in 2018
Table Recombinant Antibody Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Antibody Production by Regions 2014-2019 (K Units)
Table Global Recombinant Antibody Production Market Share by Regions 2014-2019
Figure Global Recombinant Antibody Production Market Share by Regions in 2018
Table Global Recombinant Antibody Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Antibody Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Antibody Revenue Market Share by Regions in 2018
Table Global Recombinant Antibody Consumption by Regions 2014-2019 (K Units)
Table Global Recombinant Antibody Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure North America Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure Europe Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure Europe Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure China Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure China Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure Japan Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure Japan Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure Southeast Asia Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure India Recombinant Antibody Production Growth Rate 2014-2019 (K Units)
Figure India Recombinant Antibody Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Antibody Production, Consumption Import and Export (K Units)
Figure Global Consumption Recombinant Antibody Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Antibody Market Share by Application (2014-2019)
Table Abnova Recombinant Antibody Production Sites and Area Served
Table Abnova Recombinant Antibody Product Introduction, Application and Specification
Table Abnova Recombinant Antibody Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abnova Recombinant Antibody Production Growth Rate (2014-2019)
Table Abnova Recombinant Antibody Production Market Share (2014-2019)
Figure Abnova Recombinant Antibody Revenue Market Share (2014-2019)
Table Abnova Recombinant Antibody Main Business and Markets Served
Table Medix Biochemica Recombinant Antibody Production Sites and Area Served
Table Medix Biochemica Recombinant Antibody Product Introduction, Application and Specification
Table Medix Biochemica Recombinant Antibody Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Medix Biochemica Recombinant Antibody Production Growth Rate (2014-2019)
Table Medix Biochemica Recombinant Antibody Production Market Share (2014-2019)
Figure Medix Biochemica Recombinant Antibody Revenue Market Share (2014-2019)
Table Medix Biochemica Recombinant Antibody Main Business and Markets Served
Table GE Healthcare Recombinant Antibody Production Sites and Area Served
Table GE Healthcare Recombinant Antibody Product Introduction, Application and Specification
Table GE Healthcare Recombinant Antibody Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Recombinant Antibody Production Growth Rate (2014-2019)
Table GE Healthcare Recombinant Antibody Production Market Share (2014-2019)
Figure GE Healthcare Recombinant Antibody Revenue Market Share (2014-2019)
Table GE Healthcare Recombinant Antibody Main Business and Markets Served
Table SinoBiological Recombinant Antibody Production Sites and Area Served
Table SinoBiological Recombinant Antibody Product Introduction, Application and Specification
Table SinoBiological Recombinant Antibody Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table SinoBiological Recombinant Antibody Production Growth Rate (2014-2019)
Table SinoBiological Recombinant Antibody Production Market Share (2014-2019)
Figure SinoBiological Recombinant Antibody Revenue Market Share (2014-2019)
Table SinoBiological Recombinant Antibody Main Business and Markets Served
Table Bioventix Recombinant Antibody Production Sites and Area Served
Table Bioventix Recombinant Antibody Product Introduction, Application and Specification
Table Bioventix Recombinant Antibody Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bioventix Recombinant Antibody Production Growth Rate (2014-2019)
Table Bioventix Recombinant Antibody Production Market Share (2014-2019)
Figure Bioventix Recombinant Antibody Revenue Market Share (2014-2019)
Table Bioventix Recombinant Antibody Main Business and Markets Served
Figure Global Recombinant Antibody Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Recombinant Antibody Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Antibody Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Antibody Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Recombinant Antibody Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Recombinant Antibody by Type (2019-2025)
Table Global Consumption (K Units) of Recombinant Antibody by Application (2019-2025)
Table Recombinant Antibody Distributors List
Table Recombinant Antibody Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abnova、Medix Biochemica、GE Healthcare、SinoBiological、Bioventix、

★調査レポート[世界の組換体抗体市場 2019年] (コード：DATA909X14170)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換体抗体市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のB3GL2抗体市場 2019年
    DATA909X04301 / QYResearch / 2019年11月15日 / ※本調査レポートは、B3GL2抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、pAbs、mAbに、用途別には、バイオサイエンス企業、病院＆クリニック、大学＆機関、その他にセグメント区分し、B3GL2抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・B3GL2抗体の世界市場概要 ・B3GL2抗体の製造コスト構成分析 ・B3GL2抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・B3GL2抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・B3GL2抗体のセグメント分析（種類別） （pAbs、mAb）...The global B3GL2 Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B3GL2 Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall B3GL2 Antibody market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of B3GL2 Antibody in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their B3GL2 Antibody manufacturing...
  • 世界の組み換えヒトエンドスタチン市場 2019年
    DATA909X14173 / QYResearch / 2019年11月20日 / ※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、組み換えヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組み換えヒトエンドスタチンの世界市場概要 ・組み換えヒトエンドスタチンの製造コスト構成分析 ・組み換えヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組み換えヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組み換えヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他）...The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Endostatin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の抗体産生市場 2019年
    DATA909X03628 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗体産生の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ポリクローナル抗体、モノクローナル抗体、マウス、キメラ、ヒト化に、用途別には、製薬＆バイオ企業、研究室、その他にセグメント区分し、抗体産生の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗体産生の世界市場概要 ・抗体産生の製造コスト構成分析 ・抗体産生の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗体産生の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗体産生のセグメント分析（種類別） （ポリクローナル抗体、モノクローナル抗体、マウス、キメラ、ヒト化）...The global Antibody Production market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antibody Production volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Production market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antibody Production in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Antibody Production manufacturing...
  • 世界の組換え第VIII因子市場 2019年
    DATA909X14171 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換え第VIII因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、200IU、250IUに、用途別には、病院、薬局にセグメント区分し、組換え第VIII因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え第VIII因子の世界市場概要 ・組換え第VIII因子の製造コスト構成分析 ・組換え第VIII因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え第VIII因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え第VIII因子のセグメント分析（種類別） （200IU、250IU）...The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Factor VIII market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Factor VIII in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の組換えヒルジン薬市場 2019年
    DATA909X14172 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えヒルジン薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、12000 ATU / mg、16000 ATU / mg、16000 ATU / mg、その他に、用途別には、血栓症、腫瘍疾患、その他にセグメント区分し、組換えヒルジン薬の世界市場を分析しました。...The global Recombinant Hirudin Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Hirudin Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Hirudin Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Hirudin Medicine in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の抗体フラグメント市場 2019年
    DATA909X03627 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗体フラグメントの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、F(ab)フラグメント、F(ab’)2フラグメントに、用途別には、がん、免疫不全、その他にセグメント区分し、抗体フラグメントの世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗体フラグメントの世界市場概要 ・抗体フラグメントの製造コスト構成分析 ・抗体フラグメントの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗体フラグメントの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗体フラグメントのセグメント分析（種類別） （F(ab)フラグメント、F(ab’)2フラグメント）...The global Antibody Fragments market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antibody Fragments volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Fragments market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antibody Fragments in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Antibody Fragments manufacturing...
  • 世界の組換えペプチド市場 2019年
    DATA909X14174 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルカゴン、カルシトニン、その他に、用途別には、インスリン、ヒト成長ホルモン、血液製剤、その他にセグメント区分し、組換えペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換えペプチドの世界市場概要 ・組換えペプチドの製造コスト構成分析 ・組換えペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換えペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換えペプチドのセグメント分析（種類別） （グルカゴン、カルシトニン、その他）...The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Recombinant Peptides manufacturing...
  • 世界の抗核抗体(ANA)テスト市場 2019年
    DATA909X03661 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗核抗体(ANA)テストの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、試薬＆アッセイキット、システム、ソフトウェア＆サービスに、用途別には、病院、臨床検査室、診療所検査室、その他にセグメント区分し、抗核抗体(ANA)テストの世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗核抗体(ANA)テストの世界市場概要 ・抗核抗体(ANA)テストの製造コスト構成分析 ・抗核抗体(ANA)テストの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗核抗体(ANA)テストの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗核抗体(ANA)テストのセグメント分析（種類別） （試薬＆アッセイキット、システム、ソフトウェア＆サービス）...The global Antinuclear Antibody (ANA) Test market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antinuclear Antibody (ANA) Test volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antinuclear Antibody (ANA) Test market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antinuclear Antibody (ANA) Test in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆